The plans could be related to $23 billion effort by Swiss pharmaceutical Novartis to expand its manufacturing capabilities in ...

Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...

The agreement as a strategic milestone in Egypt’s efforts to localize pharmaceutical manufacturing and introduce advanced ...

The country’s pharmaceutical industry has achieved remarkable growth over the past four decades. Meeting 98 percent of the ...

The deal between the U.S. and European Union on trade in pharmaceutical products promises to have a deep impact on the ...

The company said the certificates remain valid for three years. They cover all activities at the site’s Helix building, ...

Robert Armstrong There has been a wild and hectic series of M&A deals in the pharmaceuticals industry. We are now headed for ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...

Moderated by pharmaphorum’s web editor Nicole Raleigh, the session featured three expert panellists: Mo Rice, Vice President ...